Homepage
Author:
Crystalys Therapeutics / Russo Partners
Posted Date:
February 12, 2026
Crystalys Therapeutics Appoints Tim Walbert, Former Horizon Therapeutics CEO, as Independent Board Director
Crystalys Therapeutics / Russo Partners
February 12, 2026
Crystalys Therapeutics Expands Phase 3 RUBY Study With First Patients Dosed at European Sites
Crystalys Therapeutics / Russo Partners
February 2, 2026